{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:47:17Z","timestamp":1781668037673,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.numecd.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T20:45:26Z","timestamp":1415738726000},"page":"148-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Type of myocardial infarction presentation in patients with chronic kidney disease"],"prefix":"10.1016","volume":"25","author":[{"given":"L.A.","family":"Ferrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Staiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Di Fronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"de Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2014.11.002_bib1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2014.11.002_bib2","first-page":"85","article-title":"Chronic kidney disease","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Eff Cardiovasc Syst Circ"},{"key":"10.1016\/j.numecd.2014.11.002_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2005080834","article-title":"Endothelial dysfunction contributes to renal function associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study","volume":"17","author":"Stam","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2014.11.002_bib4","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.ATV.19.5.1168","article-title":"Nitric oxide production is reduced in patients with chronic renal failure","volume":"19","author":"Wever","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2014.11.002_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1681\/ASN.2004070582","article-title":"Reduced agonist-induced endothelium-dependent vasodilation in uremiais attributable to an impairment of vascular nitric oxide","volume":"16","author":"Passauer","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2014.11.002_bib6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1523-1755.2002.00166.x","article-title":"Endothelial dysfunction and hypertension in 5\/6 nephrectomized rats are mediated by vascular superoxide","volume":"61","author":"Hasdan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2014.11.002_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/hy0102.100540","article-title":"Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency","volume":"39","author":"Vaziri","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2014.11.002_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"On behalf of the American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics \u2013 2011 update: a report from the American heart association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"issue":"Suppl.","key":"10.1016\/j.numecd.2014.11.002_bib9","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1016\/j.cjca.2011.08.110","article-title":"Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment \u2013 part 1: non-ST\u2013segment elevation ACS","volume":"27","author":"Fitchett","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.numecd.2014.11.002_bib10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/oxfordjournals.eurheartj.a015434","article-title":"The burden of cardiovascular diseases mortality in Europe. Task force of the European Society of cardiology on cardiovascular mortality and morbidity statistics in Europe","volume":"18","author":"Sans","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2014.11.002_bib11","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/euhj.2000.2185","article-title":"The ENACT study: a pan-European survey of acute coronary syndromes. European network for acute coronary treatment","volume":"21","author":"Fox","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2014.11.002_bib12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014a consensus document of the Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2014.11.002_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijcard.2013.03.154","article-title":"STEMI and NSTEMI: a mono versus a multivessel disease?","volume":"168","author":"Ferrara","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2014.11.002_bib14","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2014.11.002_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2014.11.002_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2014.11.002_bib17","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"issue":"284","key":"10.1016\/j.numecd.2014.11.002_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"16","author":"Antman","year":"2000","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.numecd.2014.11.002_bib19","first-page":"S4","article-title":"Standards of medical care in diabetes\u20142006","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.11.002_bib20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"The task force for the management of arterial hypertension of the European Society of hypertension (ESH) and of the European Society of Cardiology (ESC) 2013 ESH\/ESC guidelines for the management of arterial hypertension","volume":"31","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2014.11.002_bib21","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2001","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.numecd.2014.11.002_bib22","first-page":"S51","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report","volume":"6","author":"National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.numecd.2014.11.002_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2014.11.002_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.amjcard.2007.02.083","article-title":"Comparison of outcome in patients with ST-elevation versus non\u2013ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National heart, Lung, and blood Institute Dynamic Registry)","volume":"100","author":"Abbott","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2014.11.002_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCIMAGING.112.000165","article-title":"Non-culprit coronary plaque characteristics of chronic kidney disease","volume":"6","author":"Kato","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.numecd.2014.11.002_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","article-title":"End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions","volume":"34","author":"Ritz","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2014.11.002_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/HJH.0b013e3283220ecd","article-title":"Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease","volume":"27","author":"Nardi","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2014.11.002_bib28","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.CIR.88.4.1444","article-title":"Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events","volume":"88","author":"Devereux","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2014.11.002_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1445-5994.2010.02226.x","article-title":"Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the atherosclerosis and folic acid supplementation trial","volume":"41","author":"Zoungas","year":"2011","journal-title":"Intern Med J"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314003263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314003263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T17:59:30Z","timestamp":1598464770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475314003263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0939475314003263"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2014.11.002","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type of myocardial infarction presentation in patients with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}